Benzethonium Chloride Review Urged By Lonza Before Final Monograph
This article was originally published in The Rose Sheet
Executive Summary
FDA should complete a safety review of benzethonium chloride as a Category I active ingredient for the healthcare antiseptic products monograph before finalizing the rule, chemical ingredient supplier Lonza says in a recent letter to the agency.
You may also be interested in...
Benzethonium Chloride Finished Product Studies Support Efficacy – Lonza
Safety and efficacy studies on the use of benzethonium chloride in finished product formulas support a Category I classification of the ingredient in the healthcare antiseptic monograph, chemical supplier Lonza says in a May 15 citizen petition to FDA
Benzethonium Chloride Finished Product Studies Support Efficacy – Lonza
Safety and efficacy studies on the use of benzethonium chloride in finished product formulas support a Category I classification of the ingredient in the healthcare antiseptic monograph, chemical supplier Lonza says in a May 15 citizen petition to FDA
Benzethonium Chloride Bioavailability, Toxicity Studies Planned By Lonza
The safety of benzethonium chloride in differing vehicles will be tested through a combination of in vitro dermal penetration studies and a toxicokinetic study in rats to be conducted by Lonza, Inc.